Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul I. van Spiegel
Paul I. van Spiegel
Nabi Biopharmaceuticals
Smoking cessation
Medicine
Nicotine
Placebo
NicVAX
3
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial
2014
Addiction
Philippe Hoogsteder
Daniel Kotz
Paul I. van Spiegel
Wolfgang Viechtbauer
Onno C. P. van Schayck
Show All
Source
Cite
Save
Citations (50)
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
2012
BMC Public Health
Philippe Hoogsteder
Daniel Kotz
Paul I. van Spiegel
Wolfgang Viechtbauer
Ruth Brauer
Paul Kessler
Matthew Kalnik
Raafat Fahim
Onno C. P. van Schayck
Show All
Source
Cite
Save
Citations (23)
Supporting smoking cessation in healthcare: obstacles in scientific understanding and tobacco addiction management
2010
Health
Dianne de Korte
Onno C. P. van Schayck
Paul I. van Spiegel
Ad A. Kaptein
Alfred Sachs
Maureen Rutten-van Mölken
Niels Chavannes
Trudi Tromp-Beelen
Rik Bes
Remi Allard
Gérard Peeters
Leo Kliphuis
Jan Willem Schouten
Lies van Gennip
Rene Van Ommen
J D Asin
Show All
Source
Cite
Save
Citations (8)
1